[Evaluation of the anti-arrhythmia effectiveness of Phenazolinum Polfa in paroxysmal atrial fibrillation].
Srzednicki
M
M
Kliniki Choroby Wieńcowej Instytutu Kardiologii w Warszawie.
Sadowski
Z
Z
Kulikowski
A
A
D000328:Adult; D000368:Aged; D000865:Antazoline / Q000008:administration & dosage*; D000889:Anti-Arrhythmia Agents; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006339:Heart Rate / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged
D000889:Anti-Arrhythmia Agents; D000865:Antazoline
Ocena skuteczności antyarytmicznej Phenazolinum Polfa w napadowym migotaniu przedsionków.